Ymmunobio

Basel, Switzerland

Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.

Nov 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Ymmunobio's investors?

Ymmunobio's investors include Innosuisse.

Where is Ymmunobio headquartered?

Ymmunobio is headquartered in Basel, Switzerland.

What does Ymmunobio do?

Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.

What stage is Ymmunobio at?

Ymmunobio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 8, 2024.

MLA

"Ymmunobio — Funding & Investors." VCBacked, November 8, 2024, https://www.vcbacked.co/company/ymmunobio. Accessed July 2, 2026.

APA

VCBacked. (2024). Ymmunobio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ymmunobio

Wikipedia (cite web)

{{cite web |title=Ymmunobio — Funding & Investors |url=https://www.vcbacked.co/company/ymmunobio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 8, 2024.